Join the club for FREE to access the whole archive and other member benefits.


Global medicines company for developing and producing drugs.

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.

Visit website:

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

Novartis Creations


Prescription gene therapy product for treatment of inherited retinal disease

People at Novartis

Company Representative

Head of informatics systems at Novartis Institutes for Biomedical Research in Cambridge.

Company Representative

Chief Executive Officer of Novartis.

Novartis News

Inherited blindness can now be cured with gene therapy

BBC - 29-Apr-2021

A breakthrough gene therapy restores eyesight in patients with rare eye disease


$95M raised by Taysha for clinical trials of four new gene therapies

FierceBiotech - 05-Aug-2020

Company has gathered support from investors to quickly lead therapies to clinic then market


Role of immune cells in reversal of aging process- A study in mice models

University of Bern - 06-Jul-2020

Manipulation of Eosinophils in belly fat to promote healthy aging


Adicet merges with resTorbio for CAR T-cell therapy pipeline funding

FierceBiotech - 30-Apr-2020

The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year


First gene therapy for a rare eye disease, now NHS-approved

BBC - 17-Feb-2020

This life-changing new gene therapy will halt sight loss and improve vision


Competitors in big pharma accused of conspiring to inflate generic drug prices

Independent - 12-May-2019

Inflated prices of more than 100 generic drugs by as much as 1000 per cent


We Need a Different Approach to Drug Discovery

Fortune - 12-Mar-2018

Discovery of new cardiovascular medicines at lowest point in decades. Need a more focused medici...


FDA Target Rogue Gene Therapy Clinics

New York Times - 16-Nov-2017

FDA issued new guidelines for expedited review of stem cell and gene therapies. Will crack down ...


IBM Watson to make breast cancer treatment recommendations

pharmaphorum - 06-Jun-2017

Lessons learnt may be applied by other oncologists in future


Is This the Anti-Aging Pill We’ve All Been Waiting For?

MIT Technology Review - 28-Mar-2017

Novartis sought to see whether giving low doses of everolimus to people over 65 increased their r...


Big data promise exponential change in healthcare

Financial Times - 29-Nov-2016

GlaxoSmithKline employs online technology and a data algorithm developed by F1’s elite McLaren Ap...


Are Consumers and Doctors Finally Bridging the mHealth Gap?

mHealth Intelligence - 16-Jan-2016

Review of CES 2016 – consumer-focused conference is seeing more digital health each year. Volume...


Everyday drugs could give extra years of life

New Scientist - 01-Oct-2014

Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.